Select Page

RFO – Evaluation of ACIPC’s Credentialling Program

Request for Offer (RFO)

The provision of services to undertake an evaluation of the Australasian College for Infection and Control’s Credentialling program for Infection Control Professionals.

RFO Document: ACIPC Request for Offer – Review of Credentialling

Overiew

The Australasian College for Infection Prevention and Control (ACIPC) is the peak body for Infection Prevention and Control professionals within the Australasian region and operates as a not-for profit organisation. ACIPC is seeking to engage a qualified organisation to undertake an external review of the credentialing pathways for Infection Prevention and Control (IPC) professionals.

Credentialing provides an industry recognised pathway for IPC professionals to demonstrate their knowledge, skills and attributes. The purpose of credentialing is to provide an independent standard for assessing IPC competency and knowledge and understanding of the evidence for IPC within healthcare settings.

The aim of the requested evaluation is to determine whether the credentialling assessment framework and evaluation of applicants is contemporary and adequately recognises the skills, knowledge and expertise of all ACIPC members, through a process that is rigorous, transparent, and provide consistent outcomes throughout the application process.

This evaluation is needed to ensure that ACIPC is providing its members with industry recognition through its flagship program in the region. The credentialing assessment framework needs to provide recognition of the diversity of careers and breadth of the profession, by demonstrating recognition of the applicant’s role and expertise, including the acknowledgement of diverse and specialist IPC roles. Further, recognition needs to encompass acknowledgment of contributions to the profession and different professional pathways, including leadership roles with an Infection Prevention and Control focus.

Due Date

Offers will be accepted until 6 p.m. (AEDT) on 5 February 2025.